Page 26 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 26

Sensitive combination products   15




                                    Flow chart for Varithena™
                                 (polidocanol injectable foam) 1%
                                 combination product manufacture
                  Valve
                manufacture   Controlled
                and assembly  environment
                                                       Varithena™ Bi-can
                Gamma                                 fully assembled unit
                                    Gamma
                                                          (FAU)
                         Oxygen can
                         fill and closure
                                               Bi-can assembled  steam
                         Cleanroom             into FAU, sealed
                                               in Tyvek pouch
                        Polidocanol:CO 2                          Finished product:
                          can fill and         Cleanroom  Gamma    Boxed FAU with
                           closure                                   3 x VTUs
                                                  VTU               + accessories
                                                blister pack
                                                assembly
                              filter
                         Polidocanol
                           solution             Varithena
                         preparation           Transfer Unit™  Controlled
                                                           environment
                                            moulding and assembly
                 Fig. 2.5  Flow chart for the manufacture of Varithena (polidocanol injectable
                 foam) 1% drug-device combination product manufacture.

                 gas and the other polidocanol solution and CO 2 , to be sterilized as a bi-
                 can assembly and the gases combined at the point of use. A decision was
                 originally taken to continue to gamma sterilize the oxygen canister once
                 filled and sealed but not the polidocanol canister. This was written into the
                 procedures and shelf-life data generated; this provides somewhat of a bar-
                 rier moving forwards in the process development, and if that superfluous
                 gamma irradiation step is to be removed, a great deal of work is required to
                 justify this to regulatory bodies and to generate new shelf-life data. The final
                 assembled product is co-packaged with the Varithena Transfer Units needed
                 to administer the foam from the activated canister (which itself undergoes
                 a separate gamma sterilization) and the whole product is terminally steam
                 sterilized. Decisions taken early on and changes to the design process have
                 led to an over-cumbersome process that is extremely difficult to change.
                 Moreover, extensive work has had to be undertaken to demonstrate that
                 the components of the finished unit are not adversely affected by the several
                 sterilization steps they are subjected to through the manufacturing process.
                 Ideally, learn as much about the product requirements through the target
                 product profile up front, spend time planning and designing a lean and ef-
                 ficient process, execute in a timely fashion, and minimize change as much
                 as possible on the way.
   21   22   23   24   25   26   27   28   29   30   31